A newly approved ‘living drug’ could save more cancer patients’ lives
Favicon 
notallnewsisbad.com

A newly approved ‘living drug’ could save more cancer patients’ lives

Tumor-infiltrating lymphocyte, or TIL, therapy is the first T cell treatment for solid tumors. It fights melanoma and maybe other cancers too. Source: A newly approved ‘living drug’ could save more cancer patients’ lives Very exciting.